159 related articles for article (PubMed ID: 12437635)
1. Molecular histogenesis of plasmablastic lymphoma of the oral cavity.
Gaidano G; Cerri M; Capello D; Berra E; Deambrogi C; Rossi D; Larocca LM; Campo E; Gloghini A; Tirelli U; Carbone A
Br J Haematol; 2002 Dec; 119(3):622-8. PubMed ID: 12437635
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status.
Hassan A; Kreisel F; Gardner L; Lewis JS; El-Mofty SK
Head Neck Pathol; 2007 Dec; 1(2):150-5. PubMed ID: 20614267
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma.
Csernus B; Timár B; Fülöp Z; Bognár A; Szepesi A; László T; Jáksó P; Warnke R; Kopper L; Matolcsy A
Leuk Lymphoma; 2004 Oct; 45(10):2105-10. PubMed ID: 15370257
[TBL] [Abstract][Full Text] [Related]
5. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
6. MUM1: a step ahead toward the understanding of lymphoma histogenesis.
Gaidano G; Carbone A
Leukemia; 2000 Apr; 14(4):563-6. PubMed ID: 10764139
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Carbone A; Gaidano G; Gloghini A; Larocca LM; Capello D; Canzonieri V; Antinori A; Tirelli U; Falini B; Dalla-Favera R
Blood; 1998 Feb; 91(3):747-55. PubMed ID: 9446632
[TBL] [Abstract][Full Text] [Related]
8. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
Capello D; Fais F; Vivenza D; Migliaretti G; Chiorazzi N; Gaidano G; Ferrarini M
Leukemia; 2000 May; 14(5):811-5. PubMed ID: 10803511
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
10. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.
Pasqualucci L; Migliazza A; Fracchiolla N; William C; Neri A; Baldini L; Chaganti RS; Klein U; Küppers R; Rajewsky K; Dalla-Favera R
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11816-21. PubMed ID: 9751748
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders.
Abed N; Casper JT; Camitta BM; Margolis D; Trost B; Orentas R; Chang CC
Bone Marrow Transplant; 2004 Feb; 33(3):321-7. PubMed ID: 14688820
[TBL] [Abstract][Full Text] [Related]
12. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia.
Pasqualucci L; Neri A; Baldini L; Dalla-Favera R; Migliazza A
Cancer Res; 2000 Oct; 60(20):5644-8. PubMed ID: 11059755
[TBL] [Abstract][Full Text] [Related]
13. Plasmablastic lymphoma: a clinicopathologic correlation.
Folk GS; Abbondanzo SL; Childers EL; Foss RD
Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
[TBL] [Abstract][Full Text] [Related]
14. Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas.
Boy SC; van Heerden MB; Babb C; van Heerden WF; Willem P
Oral Oncol; 2011 Sep; 47(9):883-7. PubMed ID: 21783402
[TBL] [Abstract][Full Text] [Related]
15. Emerging pathways in the development of AIDS-related lymphomas.
Carbone A
Lancet Oncol; 2003 Jan; 4(1):22-9. PubMed ID: 12517536
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
[TBL] [Abstract][Full Text] [Related]
17. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
19. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
[TBL] [Abstract][Full Text] [Related]
20. Extra-oral plasmablastic lymphoma: report of a case and review of literature.
Tavora F; Gonzalez-Cuyar LF; Sun CC; Burke A; Zhao XF
Hum Pathol; 2006 Sep; 37(9):1233-6. PubMed ID: 16938530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
